PLAY PODCASTS
2023.36 Tech & Economy Unpacked: Insights into Markets, Energy, and Innovation

2023.36 Tech & Economy Unpacked: Insights into Markets, Energy, and Innovation

Telltales · Mike Nicoletti and Jason

September 7, 202332m 51s

Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this week’s episode...

[00:01:26] EXHIBIT A: US. GOV’T REVENUES AND EXPENSES - Hunt delves into the U.S. government's legislative process for revenues and expenses, emphasizing the challenges and implications of budget deficits. The focus is on the role of committees and the Congressional Budget Office's numbers for the year.

[00:04:55] EXHIBIT B: US GAS DEMAND / SUPPLY - Hunt discusses the balance between U.S. gas demand and supply, pointing out that increased supply has managed to counteract the rising demand. It also hints at the average gas prices and the future outlook for 2024 and 2025.

[00:07:01] EXHIBIT C: WORLD OIL SUPPLY / DEMAND - Hunt talks about global oil demand and supply, with a focus on political issues between leading producers like Saudi Arabia and the United States.

[00:08:42] PAGE 1: AAPL / GOOG / TSLA - Jason comments on Google's search result presentation and the unclear nature of paid positions in the results.

[00:09:52] PAGE 2: MSFT / CRM / SNOW / ORCL - Mike and Jason discuss tech companies such as Microsoft, Salesforce, Snowflake, and Oracle, with a focus on free cash flow and back-office functions. They touch upon how companies are adapting to the times.

[00:20:59] PAGE 3: NVDA/AMD/INTC/TSMC/ASML - The hosts discuss the significance of ASML's latest lithography machines and their impact on semiconductor manufacturing.

[00:27:43] PAGE 15: PFE / MRNA / LNTH / BNTX / VRTX - The final section is a brief discussion on biotech companies like Pfizer, Moderna, and others. It also touches upon potential future treatments being developed by Vertex that would replace opioid painkillers.

This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com